Reduced plasma visfatin in end-stage renal disease is associated with reduced body fat mass and elevated serum insulin - Nüsken, KD; Petrasch, M; Rauh, M; Stöhr, W; Nüsken, E; Schneider, H; Dötsch, J (Experimental and Clinical Endocrinology & Diabetes, 2007)